Differential activity of glycosaminoglycans on colony-forming cells from cord blood. Preliminary results.

[1]  N. Volpi.  Inhibition of human leukocyte elastase activity by heparins: influence of charge density. , 1996, Biochimica et biophysica acta.

[2]  R. Borojevic,et al.  GM‐CSF and IL‐3 activities in schistosomal liver granulomas are controlled by stroma‐associated heparan sulfate proteoglycans , 1996, Journal of leukocyte biology.

[3]  J. Wagner.  Umbilical cord blood transplantation , 1995, Transfusion.

[4]  J. Wagner,et al.  Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease , 1995, The Lancet.

[5]  S. Ben‐Sasson,et al.  Control of Cell Proliferation by Heparan Sulfate and Heparin-Binding Growth Factors , 1995, Thrombosis and Haemostasis.

[6]  O. Katoh,et al.  Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance. , 1995, Cytokine.

[7]  A. Conte,et al.  Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship. , 1994, Experimental cell research.

[8]  N. Volpi.  Fractionation of heparin, dermatan sulfate, and chondroitin sulfate by sequential precipitation: a method to purify a single glycosaminoglycan species from a mixture. , 1994, Analytical biochemistry.

[9]  A. Conte,et al.  Effects of chondroitin sulfates with different structures on leukemia cells: U-937 cell proliferation and differentiation. , 1993, Leukemia research.

[10]  G. David.  Integral membrane heparan sulfate proteoglycans , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  A. Isaksson,et al.  L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors. , 1993, Experimental cell research.

[12]  C. Rider,et al.  Selective and differential binding of interleukin (IL)‐1α, IL‐1β, IL‐2 and IL‐6 to glycosaminoglycans , 1992 .

[13]  M. Gordon,et al.  Binding of primitive hematopoietic progenitor cells to marrow stromal cells involves heparan sulfate. , 1992, Blood.

[14]  M. Tavassoli,et al.  Membrane-associated chondroitin sulfate proteoglycan and fibronectin mediate the binding of hemopoietic progenitor cells to stromal cells. , 1992, Experimental cell research.

[15]  T. Hardingham,et al.  Proteoglycans: many forms and many functions , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  R. Tiozzo,et al.  Effect of heparin derived fractions on the proliferation and protein synthesis of cells in culture. , 1991, Thrombosis research.

[17]  Y. Kita,et al.  Role of glycosaminoglycans in the regulation of T cell proliferation induced by thymic stroma-derived T cell growth factor. , 1991, Journal of Immunology.

[18]  R L Jackson,et al.  Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. , 1991, Physiological reviews.

[19]  Erkki Ruoslahti,et al.  Proteoglycans as modulators of growth factor activities , 1991, Cell.

[20]  T. Dexter,et al.  Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis , 1988, Nature.

[21]  T. Imamura,et al.  Heparan sulfate and heparin as a potentiator or a suppressor of growth of normal and transformed vascular endothelial cells. , 1987, Experimental cell research.

[22]  R. J. Mello,et al.  Extracellular mammalian polysaccharides: glycosaminoglycans and proteoglycans. , 1987, Journal of chromatography.

[23]  A. La Gioia,et al.  A case of idiopathic myelofibrosis with poorly differentiated circulating blasts. The role of the fixative in the peroxidase reaction. , 1986, Haematologica.

[24]  A. Poole.  Proteoglycans in health and disease: structures and functions. , 1986, The Biochemical journal.

[25]  J. Singer,et al.  Proteoglycans in human long-term bone marrow cultures: biochemical and ultrastructural analyses. , 1986, Blood.

[26]  J. Gabrilove,et al.  Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. , 1986, Science.

[27]  Y. M. Michelacci,et al.  Structural differences of dermatan sulfates from different origins. , 1986, Carbohydrate research.

[28]  T. Suda,et al.  Proliferation and differentiation in culture of mast cell progenitors derived from mast cell‐deficient mice of genotype W/Wv , 1985, Journal of cellular physiology.

[29]  R. Revoltella,et al.  Growth factors that stimulate human granulocyte—macrophage colony formation produced by the cell line CM‐S , 1984, Journal of cellular physiology.

[30]  G. Johnson,et al.  Pure and mixed erythroid colony formation in vitro stimulated by spleen conditioned medium with no detectable erythropoietin. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Kincade,et al.  Heparan sulfate proteoglycans mediate interleukin-7-dependent B lymphopoiesis. , 1999, Blood.

[32]  E Ruoslahti,et al.  Extracellular matrix/growth factor interactions. , 1992, Cold Spring Harbor symposia on quantitative biology.

[33]  L. Kjellén,et al.  Proteoglycans: structures and interactions. , 1991, Annual review of biochemistry.

[34]  T. Maciag,et al.  The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.

[35]  E. Ruoslahti.  Structure and biology of proteoglycans. , 1988, Annual review of cell biology.

[36]  M. Greaves,et al.  Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment , 1987, Nature.

[37]  D. Heinegård,et al.  [17] Isolation and characterization of proteoglycans , 1987 .

[38]  J. Radford,et al.  Effects of recombinant human granulocyte colony-stimulating factor (CSF), human granulocyte macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture. , 1990, Blood.